Velusetrag for the treatment of chronic constipation
Authors:
- 7 June 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 25 (8) , 985-990
Abstract
Chronic constipation is a frequent complaint in daily clinical practice. Notwithstanding the availability of numerous drugs, its treatment it is still unsatisfactory. However, new emerging treatments are in the pipeline and some drugs seem to be promising; among these velusetrag, a selective 5-HT4 receptors agonist. An in depth Medline literature search was performed concerning topics related to the treatment of constipated patients with velusetrag. In addition, abstracts concerning the topic were searched by hand in our libraries. After analyzing the available data, the authors feel that velusetrag may likely improve symptoms and the quality of life of chronically constipated subjects. However, additional data is needed to fully understand the safety and efficacy of velusetrag, particularly in patients on long-term therapy. Thanks to the once-daily dosing and the pharmacologic properties, velusetrag could be used as a single agent or in association with other drugs. In the future, this drug holds the potential to be an effective adjunct to the therapeutic armamentarium for chronic constipation.Keywords
This publication has 42 references indexed in Scilit:
- Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation ToolJournal of Neurogastroenterology and Motility, 2013
- Systematic review: cardiovascular safety profile of 5‐HT4agonists developed forgastrointestinaldisordersAlimentary Pharmacology & Therapeutics, 2012
- Diagnosis and treatment of chronic constipation - a European perspectiveNeurogastroenterology & Motility, 2011
- A Qualitative Study of Quality of Life and the Experience of Complementary and Alternative Medicine in Korean Women With ConstipationGastroenterology Nursing, 2011
- Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response studyAlimentary Pharmacology & Therapeutics, 2010
- Audit of Constipation in a Gastroenterology Referral CenterDigestive Diseases and Sciences, 2007
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- Nerves, Reflexes, and the Enteric Nervous SystemJournal of Clinical Gastroenterology, 2005
- Neurotransmitters Mediating the Intestinal Peristaltic Reflex in the MouseThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipationGut, 2000